As of Sep 30
| +2.54 / +2.59%|
The 25 analysts offering 12-month price forecasts for Bayer have a median target of 117.42, with a high estimate of 141.76 and a low estimate of 91.06. The median estimate represents a +16.84% increase from the last price of 100.50.
The current consensus among 25 polled investment analysts is to Hold stock in Bayer. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.